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PURPOSE. To investigate retinal structure in subjects with CNGA3-associated achromatopsia
and evaluate disease symmetry and intrafamilial variability.
METHODS. Thirty-eight molecularly confirmed subjects underwent ocular examination, optical
coherence tomography (OCT), and nonconfocal split-detection adaptive optics scanning light
ophthalmoscopy (AOSLO). OCT scans were used for evaluating foveal hypoplasia, grading
foveal ellipsoid zone (EZ) disruption, and measuring outer nuclear layer (ONL) thickness.
AOSLO images were used to quantify peak foveal cone density, intercell distance (ICD), and
the coefficient of variation (CV) of ICD.
RESULTS. Mean (6SD) age was 25.9 (613.1) years. Mean (6 SD) best corrected visual acuity
(BCVA) was 0.87 (60.14) logarithm of the minimum angle of resolution. Examination with
OCT showed variable disruption or loss of the EZ. Seven subjects were evaluated for disease
symmetry, with peak foveal cone density, ICD, CV, ONL thickness, and BCVA not differing
significantly between eyes. A cross-sectional evaluation of AOSLO imaging showed a mean
(6SD) peak foveal cone density of 19,844 (613,046) cones/mm2. There was a weak negative
association between age and peak foveal cone density (r ¼ 0.397, P ¼ 0.102), as well as
between EZ grade and age (P ¼ 0.086).
CONCLUSIONS. The remnant cone mosaics were irregular and variably disrupted, with
significantly lower peak foveal cone density than unaffected individuals. Variability was also
seen among subjects with identical mutations. Therefore, subjects should be considered on
an individual basis for stratification in clinical trials. Interocular symmetry suggests that both
eyes have comparable therapeutic potential and the fellow eye can serve as a valid control.
Longitudinal studies are needed, to further examine the weak negative association between
age and foveal cone structure observed here.
Keywords: adaptive optics, retinal phenotyping, retinal diseases, inherited retinal diseases,
genetics, CNGA3, cone, cone dysfunction, achromatopsia
Achromatopsia (ACHM) presents from birth or early infancy,with poor visual acuity, pendular nystagmus, photophobia,
and color vision loss in all three axes.1,2 Absent cone
electroretinogram responses is the hallmark of disease, with
normal rod function or uncommonly mildly reduced rod
responses.3–5 ACHM is an autosomal recessive disorder with a
heterogeneous genetic background. Disease-causing sequence
variants have been reported in CNGA3 (ACHM2, Online
Mendelian Inheritance in Man [OMIM] 600053),6,7 CNGB3
(ACHM3, OMIM 605080),8 GNAT2 (ACHM4, OMIM 139340),9,10
ATF6 (ACHM7, OMIM 616517),11 PDE6H (ACHM6, OMIM
I610024),12 and PDE6C (ACHM5, OMIM 600827).1
CNGA3 encodes the a subunit of the cGMP-gated cation
channel,13 located in cone outer segments, categorizing
CNGA3-associated ACHM as a ‘‘channelopathy.’’14 It has been
shown in vitro that a subunits can create functional channels in
the absence of b subunits, a property not shared by the b
subunits.15 CNGA3 variants have a far greater allelic heteroge-
neity than CNGB3.16,17 In a large cross-sectional study of
CNGA3-ACHM (n¼ 36), Zobor et al.18 reported a lack of robust
association between age and morphologic (optical coherence
tomography [OCT]) and/or functional (microperimetry) chang-
es, in agreement with a previous cross-sectional study of ACHM
by Sundaram et al.19 (n ¼ 40, with 18 having CNGA3-ACHM).
Aboshiha et al.,20 in a prospective longitudinal study (n ¼ 40,
with 18 having CNGA3-ACHM) using OCT and fundus
autofluorescence imaging, identified a slow and subtle pro-
gression of disease in a minority of subjects. These studies were
limited by the relatively low resolution of the imaging tools
used.
Adaptive optics (AO) has been used for in-depth phenotyp-
ing in inherited retinal diseases for two decades,21 by allowing
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the noninvasive visualization of the photoreceptor mosaic22–24
through the correction of the eye’s monochromatic aberra-
tions.24,25 Confocal detection of reflected light has been shown
to reflect the waveguiding ability of intact photorecep-
tors.23,26,27 Early investigations in ACHM with flood illumina-
tion-AO and confocal adaptive optics scanning light
ophthalmoscopy (AOSLO) identified dark spaces in the cone
mosaic, increased cone spacing, and/or decreased cone density
(Fig. 1A).28–31 Marked variability in the cone mosaic has been
observed across individuals; while no obvious difference has
been reported between the two most common genotypes
(CNGA3 and CNGB3), the rarer GNAT2 genotype is associated
with a significantly less-disrupted photoreceptor mosaic.30,32
Reduced reflectivity (i.e., altered waveguiding) in the majority
of remnant cones in CNGA3 and CNGB3 has also been noted,
with relative preservation in GNAT2.30 Until the advent of
nonconfocal split-detection AOSLO, it was unknown if these
dark spaces harbored nonwaveguiding cones or indicated the
loss of cones, an important question for defining the presence
of a therapeutic target. Simultaneous confocal and split-
detection AOSLO has allowed for the identification of cone
inner segment structure in these spaces (Fig. 1B)33–36 and
transformed our understanding of ACHM and participant
selection for planned and ongoing CNGA3- and CNGB3-ACHM
gene therapy trials. In confocal AOSLO imaging outside the
foveal center, due to waveguiding rods surrounding the
nonreflective dark cones, the cones can be identified (Fig.
1A). This is in contrast to the fovea, where the lack of
surrounding rods makes the identification and quantification of
cones impossible (Fig. 1C) and split-detection AOSLO is
necessary (Fig. 1D). Given the potential disconnect between
OCT and AOSLO measures of cone integrity37 and the ability of
AOSLO to directly visualize the target cones for gene
replacement, nonconfocal split-detection AOSLO imaging is
the modality of choice to identify patients most likely to benefit
from cone-directed rescue.
The current literature for CNGA3-ACHM and split-detection
AOSLO imaging is limited, with most studies focusing on the
more common CNGB3 phenotype and/or only using confocal
AOSLO. The purpose of this study was to use OCT and split-
detection AOSLO to explore the structural phenotype of
patients with molecularly-confirmed CNGA3-ACHM, and lay
the groundwork for a CNGA3 longitudinal AOSLO study to
define the cellular natural history of this disorder, in light of the
ongoing and upcoming gene therapy trials. In addition, we
examined disease symmetry at the cellular level and investi-
gated intrafamilial variability. We compared our observations
FIGURE 1. Adaptive optics scanning light ophthalmoscopy imaging in CNGA3-associated ACHM. At 28 eccentricity: (A) confocal image, with red
dots marking the dark cones. Cones are surrounded by waveguiding rods. (B) Split-detection image over the exact same region with overlying red
dots showing the cones marked in panel A, which colocalize with cone inner segments, surrounded by rods. Foveal center: (C) confocal image at
the foveal center, where the dark cones are not visible because no rods are present to delineate the dark spaces. (D) Split-detection image over the
exact same region, with visible and quantifiable cone inner segments. All images are from the same retinal montage. Scale bar: 20 lm.
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with published CNGB3-ACHM data obtained using similar
methodology.36
MATERIALS AND METHODS
The study was approved by the Ethics Committees of
Moorfields Eye Hospital and the Medical College of Wisconsin.
Written informed consent was obtained from all subjects after
explanation of the nature and possible consequences of the
study. The research followed the tenets of the Declaration of
Helsinki.
Participants
Thirty-eight ACHM subjects with likely disease-causing se-
quence variants in CNGA3 were recruited from Moorfields Eye
Hospital, London, UK, and the Medical College of Wisconsin,
Milwaukee, USA.
Ocular Examination
A full clinical history assessment and ocular examination was
carried out in 32 of the subjects, including best corrected
visual acuity (BCVA) using the Early Treatment Diabetic
Retinopathy Study chart. Axial length was obtained with the
Zeiss IOLMaster (Carl Zeiss Meditec, Jena, Germany) in order
to scale the AOSLO retinal images and the OCT scans for all
subjects.
Optical Coherence Tomography (OCT)
All subjects were imaged using the Bioptigen spectral domain
OCT (Leica Microsystems, Research Triangle Park, NC, USA)
bilaterally. Pupil dilation and cycloplegia were achieved by
instilling one drop of phenylephrine hydrochloride (2.5%) and
tropicamide (1%) in each eye prior to imaging (OCT/AOSLO).
The scanning window covered a nominal 737-mm retinal area
and vertical and horizontal scans centered at the fovea with a
nominal 7-mm scan length (120 B scans) were recorded. In
order to increase the signal-to-noise ratio, the maximum
number (n > 5) of line scans including the fovea were aligned,
registered, and averaged using ImageJ and the StackReg plugin
(National Institutes of Health).38
The outer nuclear layer (ONL) thickness was calculated at the
fovea for all subjects based on the longitudinal reflectivity profile
(LRP), as described by Huang et al.39 The LRP was 5 pixels wide
and positioned at the center of the foveal depression, and the
foveal ONL thickness was calculated as the distance between the
hyperreflective peaks of the posterior outer plexiform layer and
external limiting membrane for subjects with foveal hypoplasia.
In subjects with normal foveal excavation, the ONL thickness
was measured as the distance between the hyperreflective peaks
corresponding to the internal limiting membrane and the
external limiting membrane. A similar approach has been used
in several ACHM studies.19,36,40
The transfoveal line scans were then categorized into five
grades according to the previously reported grading system by
Sundaram et al.,19 based upon the integrity of the ellipsoid
zone (EZ): (1) continuous EZ, (2) EZ disruption, (3) EZ
absence, (4) presence of a hyporeflective zone (HRZ), and (5)
outer retinal atrophy including retinal pigment epithelium
(RPE) loss (Fig. 2). This grading allows meaningful compari-
sons with other recently published ACHM cohorts.18,36 The
nomenclature used follows the International Nomenclature for
Optical Coherence Tomography Consensus.41 Confirmation of
the aforementioned grading was established by examining
additional OCT scans acquired using the Spectralis spectral
domain OCT system (Heidelberg Engineering Inc., Heidelberg,
Germany). The grading was done by two observers indepen-
dently (MG, CSL) and any discrepancies were resolved with
consensus from a third grader (NH). The scans were also
examined for the presence of foveal hypoplasia, defined as the
presence of one or more inner retinal layers at the foveal
center.19 Both eyes were imaged for each subject, though one
eye was chosen randomly for quantitative analysis (except for
EZ grade and hypoplasia, which were assessed bilaterally).
AOSLO Imaging of the Photoreceptor Mosaic
All subjects were imaged using one of two identical AOSLO
systems, as previously described,42 at Moorfields Eye Hospital,
London, United Kingdom, and the Medical College of
Wisconsin, Milwaukee, United States. Imaging with confocal
and split-detector modes was performed, with simultaneous
acquisition, in absolute spatial and temporal registration. Split-
detection AOSLO allows for the visualization of cone inner
segments in ACHM based on a differential phase technique.33
The imaging light source was a 790-nm super-luminescent
diode (SLD; Superlum, Carrigtohill, Cork, Ireland). Image
sequences were recorded as AVI files, of 150 frames, either
at 18 and/or 1.58 square field of view (FOV). A desinusoiding
algorithm was applied to each image sequence and individual
frames were selected,43 registered,44 and averaged to increase
the signal-to-noise ratio for subsequent analysis. Images were
obtained over the fovea. The final images were combined into a
single montage (Adobe Photoshop, Adobe Systems Inc., San
Jose, CA, USA), with images from each modality overlaid on
one another, manually and/or using a custom-built automated
software.45 Images taken with a 18 FOV were analyzed
preferentially, due to the higher resolution.
The scale in degrees per pixel of each FOV was determined
using a Ronchi ruling of known spacing after each imaging
session. Then, the value was linearly scaled using the subject’s
axial length and the final micron per pixel scale was obtained
by multiplying by the retinal magnification factor of 291 lm/
degree. The AOSLO montages were aligned to color fundus
images and OCT images using common blood vessel patterns
(Adobe Photoshop). The position of the anatomic foveal center
was estimated on the AOSLO images using the aligned OCT
images. The rod-free area surrounding the foveal center was
used for further AOSLO analysis.
The eligibility criteria for AOSLO analysis were strict; low-
quality images (due to involuntary eye motion/nystagmus or
low signal-to-noise ratio), noncontiguous montages, and
montages not covering the entire rod-free area were excluded
from further analysis.
In some subjects (n ¼ 7), bilateral AOSLO images were
available for evaluating disease symmetry. The low number of
subjects with adequate bilateral data was either due to time
constraints or incomplete imaging of the fovea, in the second
eye. For each subject, the eye with the better image quality
(least eye motion, higher signal-to-noise ratio), was selected for
cross-sectional evaluation of AOSLO data.
Cone coordinates from every given foveal image were
extracted following manual annotation by a single grader (MG).
The coordinate arrays were used to assess the peak foveal cone
density (cones/mm2). A 55 3 55-lm sampling window was
used to determine the density at each pixel of the coordinate
array. The pixel location with the greatest value was the
location of peak foveal cone density, by dividing the total
number of cones by the area. In addition, the mean intercell
distance (ICD, defined as the average distance of a cone from
all its immediate neighbors) and its coefficient of variation (CV,
defined as the standard deviation of ICD divided by the mean of
ICD) were calculated for the rod-free area for all subjects with
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FIGURE 2. Remnant cone structure in different OCT EZ grades of CNGA3-associated ACHM. Left column: horizontal transfoveal OCT scans of four
subjects with different OCT EZ grades. Grade 1: Continuous EZ, grade 2: EZ disruption, grade 3: EZ absence, and grade 4: presence of a
hyporeflective zone. The red horizontal bars mark the 300-lm area represented on the AOSLO images in the right column. Right column: split-
detection AOSLO images for each subject. The red cross represents the location of peak foveal cone density.
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analyzable split-detection AOSLO, as metrics of remnant foveal
cone packing.
Statistical Methods
Statistical analysis was performed with GraphPad Prism
(version 8.0.1; GraphPad Software, San Diego, CA, USA).
Parametric and nonparametric tests were used depending on
normality tests (Shapiro-Wilk normality test), as well as
correlation coefficients (either Pearson or Spearman, respec-
tively).
RESULTS
Demographics
Thirty-eight subjects from 30 families were recruited, including
21 males (55%) and 17 females (45%), with a mean (range,
6SD) age, in years, of 25.9 (10–64, 613.1). Ten subjects were
children (under 16 years old), with a mean (range, 6SD) age,
in years, of 12.1 (10–14, 61.7). Demographics are summarized
in Table 1.
Genetics
All subjects harbored likely disease-causing sequence variants
in CNGA3, with 12 (32%) being homozygous and 24 (63%)
compound heterozygous. The remaining two of the 38
subjects (MM_0008 and MM_0009, siblings) harbored a single
heterozygous variant and were shown to have no variants in
CNGB3, with a typical ACHM phenotype. In one subject
(KS_10337), an additional CNGB3 sequence variant was
identified. In total, 33 different variants were observed in our
cohort, with 4 not previously reported to the best of our
knowledge (Table 1, marked in bold).
TABLE 1. Demographics and Genotype Summary
Subject Sex
Age,
y
Variant 1 Variant 2
cDNA
Change
AA
Change
cDNA
Change
AA
Change
MM_0002* F 41 1443-1444insC Ile482His fs*6 1706G>A Arg569His
MM_0008* F 11 536T>A Val179Asp ND† ND†
MM_0009* F 14 536T>A Val179Asp ND† ND†
MM_0014* F 35 848G>A Arg283Gln 667C>T Arg223Trp
MM_0015* F 28 848G>A Arg283Gln 667C>T Arg223Trp
MM_0016* M 30 848G>A Arg283Gln 667C>T Arg223Trp
MM_0064* F 23 1694C>T Thr565Met 661C>T Arg221Ter
MM_0164* F 35 1641C>A Phe547Leu 1641C>A Phe547Leu
MM_0165* M 13 1641C>A Phe547Leu 1641C>A Phe547Leu
MM_0167* F 28 847C>T Arg283Trp 1279C>T Arg427Cys
MM_0168* M 39 661C>T Arg221Ter 848G>A Arg283Gln
MM_0169* M 14 485A>T Asp162Val 485A>T Asp162Val
MM_0170* M 16 1642G>A Gly548Arg 67C>T Arg23Ter
MM_0171* M 22 1001C>T Ser334Phe 1360A>T Lys454Ter
MM_0239* M 37 848G>A Arg283Gln 667C>T Arg223Trp
MM_0251* F 33 661C>T Arg221Ter 661C>T Arg221Ter
MM_0358 M 10 1641C>A Phe547Leu 1641C>A Phe547Leu
MM_0385 M 37 1228C>G Arg410Trp 1228C>G Arg410Trp
MM_0386 F 22 1580T>G Leu527Arg 1805G>A Gly602Glu
MM_0387 M 18 1580T>G Leu527Arg 1805G>A Gly602Glu
MM_0396 M 27 1306C>T Arg436Trp 1279C>T Arg427Cys
MM_0397 M 18 1306C>T Arg436Trp 1279C>T Arg427Cys
MM_0398 F 14 811C>T Pro271Ser 829C>T Arg277Cys
MM_0412 M 13 1286T>C Val429Ala 608G>A Trp203Cys fs*29
MM_0418 M 18 661C>T Arg221Ter 661C>T Arg221Ter
MM_0445 M 10 1641C>A Phe547Leu 1641C>A Phe547Leu
MM_0446* F 50 67C>T Arg23Ter 67C>T Arg23Ter
JC_0578 M 32 1687C>T Arg563Cys 778G>A Asp260Asn
JC_0615 M 43 1306C>T Arg436Trp 1306C>T Arg436Trp
JC_0626 F 20 1641C>A Phe547Leu 1641C>A Phe547Leu
JC_0674 M 46 985G>T Gly329Cys 985G>T Gly329Cys
JC_0698 M 43 848G>A Arg283Gln 1228C>T Arg410Trp
JC_1240* F 24 1351dupG Val451Gly fs*3 1279C>T Arg427Cys
JC_10008 F 12 829C>T Arg277Cys 1641C>A Phe547Leu
JC_10069* M 18 847C>T Arg283Trp 542A>G Tyr181Cys
KS_10088* F 64 450-1G>A splice defect 1557G>A Met519Ile
KS_10337‡ F 17 940_942delATC Ile314del 1114C>T Pro372Ser
JC_10551 M 10 1228C>T Arg410Trp 1319G>C Trp440Ser
In bold are the previously unreported sequence variants. ND, no data; F, female; M, male; AA, amino acid.
* Subjects previously reported.19,20,30,33,76
† Only one variant identified. Phenotype consistent with CNGA3-ACHM. No variants found in CNGB3.
‡ Subject harbors an additional variant in CNGB3: c.473C>A: p.Pro158His.
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The majority of the variants resulted in single amino acid
substitutions (25/33, 76%). In addition, three different nucle-
otide changes introduced translation termination codons, three
more introduced frame shift changes, one was an intronic
change disrupting splicing, and one was a 3-base pair deletion.
The most common was c.1641C>A (p.Phe547Leu; 11 alleles,
three pedigrees), followed by c.848G>A (p.Arg283Gln; six
alleles, three pedigrees) and c.661C>T (p.Arg221Ter; six
alleles, four pedigrees). All sequence variants and protein
alterations are reported in Table 1.
Ocular Examination
The mean (range, 6SD) axial length, in mm, for all 76 eyes was
24.21 (21.46–29.61, 61.85); the mean (6SD) axial length, in
mm, for the right and left eyes was 24.25 (61.91) and 24.17
(61.81), respectively. No significant difference was noted
between eyes (P ¼ 0.344, Wilcoxon matched-pairs test). The
mean (6SD) axial length, in mm, for male and female subjects
was 24.07 (61.66) and 24.46 (62.21), respectively. No
significant difference in axial length was noted between sexes
(P¼ 0.586, Mann-Whitney test). The age, in years, of male and
female subcohorts also did not differ significantly (P ¼ 0.508,
Mann-Whitney test), with mean (6SD) 24.48 (612.28) and
27.71 (614.29), respectively.
BCVA was documented for 32 of 38 subjects. One subject
(MM_0386) had congenital light perception in one eye,
without the presence of other sequence variants or eye disease
after thorough clinical investigation, had a BCVA of 0.98
logMAR in the other eye, and was excluded from further BCVA
analysis. The mean (range, 6SD) BCVA was 0.87 logarithm of
the minimum angle of resolution (LogMAR; 0.40–1.18, 60.14).
The mean (6SD) BCVA was 0.85 LogMAR (60.14) and 0.88
LogMAR (60.15) for right and left eyes, respectively; with no
significant difference (P¼0.327, Wilcoxon matched-pairs test).
BCVA and axial length for all subjects are shown in Table 2.
OCT Imaging
Retinal Morphology. OCT revealed a variable degree of
disruption or loss of the foveal EZ and was graded as previously
published (Fig. 2).19 All subjects (n ¼ 38) had the same EZ
grade bilaterally. Four subjects (10.5%) had continuous EZ
(grade 1), 19 subjects (50.0%) had EZ disruption (grade 2), 3
subjects (7.9%) had EZ absence (grade 3), and 12 subjects
(31.6%) had presence of an HRZ (grade 4; Fig. 3A). None of the
subjects included in the study had outer retinal atrophy
including RPE loss (grade 5). In our cohort, the distribution of
age was the same across the different OCT grades (P¼ 0.086,
Kruskal-Wallis test).
Foveal ONL Thickness. The mean (6SD) ONL thickness,
in lm, for grade 1 was 92.74 (616.22), grade 2 was 78.69
(625.12), grade 3 was 64.93 (615.41), and grade 4 was 63.15
(611.57). The mean (range, 6SD) ONL thickness, in lm, for
all subjects was 74.18 (27.52–123.85, 6 21.80) (Table 2, Fig.
3B). Previously reported mean 6 SD from unaffected controls
for ONL thickness is 110.6 6 15.7 lm, with an n¼ 38 (mean
age 6 SD; 28.8 6 10.9 years);46 these values are significantly
higher than our reported values for CNGA3-ACHM (P <
0.0001, t ¼ 8.37, df ¼ 74). ONL thickness at the fovea was
measured with standard OCT. The residual Henle fiber layer
(HFL) may have been included within the ONL measurement,
but given the foveal location, only a small degree of error is
expected. The HFL comprised only 17.5% of the measured
HFLþONL thickness (range, 11.4%–24.8%) at the fovea of
healthy controls.47 Due to a small number of subjects with
grade 1 and 3 EZ, the data were not further statistically
analyzed. Grade 2 subjects had a significantly greater ONL
thickness than grade 4 subjects (P¼ 0.054, t¼ 2.005, df¼ 29).
Despite the trend toward decreasing ONL thickness with
increasing EZ grade (i.e., increasing EZ disruption/loss), there
is overlap between grades (Fig. 3C).
Foveal Hypoplasia. Hypoplasia was observed bilaterally in
25 subjects (65.8%) to variable degrees. There was no
significant difference in ONL thickness between individuals
with foveal hypoplasia and those with normal excavation of
inner retinal layers (P ¼ 0.861, Mann-Whitney test) (Table 2).
No association was found between foveal hypoplasia and EZ
grade (P ¼ 0.199, chi-square test). Subjects with foveal
hypoplasia (n ¼ 19, BCVA ¼ 0.86 LogMAR, SD ¼ 0.13) had
similar BCVA compared to subjects without foveal hypoplasia
(n¼ 12, mean BCVA¼ 0.87 LogMAR, SD¼ 0.19; P¼ 0.924, t¼
0.096, df ¼ 29).
Photoreceptor Mosaic Assessed With AOSLO
Imaging
AOSLO imaging was attempted in all recruited subjects (n ¼
38). Eighteen (47.4%) had good-quality images and met the
aforementioned eligibility criteria. If bilateral data were
available, the eye with the better image quality was included
for further analysis in all subjects. Foveal hypoplasia did not
correlate with successful AOSLO imaging (P ¼ 0.506, Fisher’s
exact test), with the main limiting factor in AOSLO acquisition
being the severity of nystagmus.
Peak Foveal Cone Density. The mean peak foveal cone
density was 19,844 cones/mm2, ranging from 6,574 cones/
mm2 to 54,785 cones/mm2 (Table 2). There was marked
variability between subjects with a SD of 13,046 cones/mm2
(Table 2); however, as expected, these values do not overlap
with previously reported normative values (range, 84,733–
247,064 cones/mm2).48,49
There was no significant difference in peak foveal cone
density between individuals with foveal hypoplasia and those
with normal excavation of inner retinal layers (P ¼ 0.974, t ¼
0.0334, df ¼ 16), a finding that has also been previously
reported for CNGB3-ACHM.36 Peak foveal cone density was
available for two subjects with EZ grade 1 and only for one
subject with EZ grade 3 and, therefore, were excluded from
statistical evaluation. There was no significant difference in
peak foveal cone density between individuals with a grade 2 EZ
and those with a grade 4 EZ (P¼ 0.129, t¼ 1.619, df¼ 13). All
peak cone density data are plotted in Figure 3D. In contrast, in
the aforementioned CNGB3 study, peak foveal cone density,
and EZ grade were significantly associated.36 Peak foveal cone
density and ONL thickness were not correlated (P¼ 0.927, r¼
0.023, Pearson correlation), in keeping with the previous
CNGB3 study.36 There was a weak negative association
between age and peak foveal cone density (P ¼ 0.102, r ¼
0.397, Pearson correlation) (Figs. 3E).
Intercell Distance. The mean (l) and SD (r) of the ICD for
each subject (n¼18) was evaluated, as well as the CV (CV¼r/
l), to measure the overall variability of ICD independent of the
value, which, as expected, varied widely. The mean ICD
(range, 6SD), in lm, was 13.40 (6.07–27.86, 65.74). As
expected, the mean ICD in CNGA3-ACHM was greater (P <
0.0001, Mann-Whitney test) than in unaffected controls (n¼ 6;
ICD mean 6 SD, 3.61 6 0.22 lm).36
Our cohort had a CV (mean 6 SD) of 0.32 6 0.1, which
was significantly higher (P ¼ 0.0002, t ¼ 4.537, df ¼ 22) than
healthy controls (n¼ 6; CV mean 6 SD, 0.13 6 0.014).36
Structural Disease Symmetry. In seven subjects, bilateral
OCT and AOSLO imaging data were obtained (one male, six
females; age (mean 6 SD), 32.6 6 11.9 years) (Table 2; Fig. 4).
All subjects had the same bilateral EZ grade; three subjects had
grade 2 and four had grade 4. Six (85.7%) subjects had bilateral
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TABLE 2. Retinal Phenotype–Optical Coherence Tomography and Adaptive Optics Imaging Summary
Subject Eye
Axial
Length,
mm
BCVA,
LogMAR
Foveal
Hypoplasia
EZ
Grade
ONL
Thickness,
lm
PFD,
Cones/mm2
ICD
Mean,
lm
ICD
SD (r)
ICD
CV
MM_0002 OD 24.4 0.74 Yes 2 76.67 16,801 13.04 3.61 0.28
OS 24.38 0.82 Yes 2 82.56 13,148 12.85 3.46 0.27
MM_0008 OD 23.14 1.06 No 2 72.74 ND ND ND ND
OS 23.08 1 No 2 ND ND ND ND ND
MM_0009 OD 21.53 0.98 No 2 72.74 22,644 9.31 2.63 0.28
OS 21.46 1 No 2 ND ND ND ND ND
MM_0014 OD 25.33 0.76 Yes 4 73.12 6,574 24.35 7.43 0.31
OS 25.54 0.72 Yes 4 75.48 7,305 25.24 8.06 0.32
MM_0015 OD 25.2 0.84 Yes 4 60.94 24,835 15.66 6.57 0.42
OS 24.75 0.78 Yes 4 49.15 32,140 10.19 4.32 0.42
MM_0016 OD 24.38 0.9 Yes 4 ND ND ND ND ND
OS 24.57 1.18 Yes 4 48.36 13,148 14.96 4.82 0.32
MM_0064 OD 22.46 0.78 No 2 27.52 9,496 11.41 2.88 0.25
OS 22.51 0.8 No 2 29.49 7,305 11.10 2.12 0.19
MM_0164 OD 25.56 0.92 Yes 2 123.85 ND ND ND ND
OS 25.83 0.8 Yes 2 ND ND ND ND ND
MM_0165 OD 24.99 0.84 Yes 4 60.94 16,801 13.36 4.12 0.31
OS 24.88 0.7 Yes 4 ND ND ND ND ND
MM_0167 OD 24.96 1.06 No 1 ND ND ND ND ND
OS 25.04 1.16 No 1 110.09 10,957 12.89 6.62 0.51
MM_0168 OD 28.74 0.8 No 2 68.80 ND ND ND ND
OS 28.24 0.92 No 2 ND ND ND ND ND
MM_0169 OD 24.77 0.74 No 1 92.39 ND ND ND ND
OS 24.19 1.12 No 1 ND ND ND ND ND
MM_0170 OD 21.79 0.78 Yes 2 55.04 27,757 8.42 1.74 0.21
OS 21.71 0.76 Yes 2 ND ND ND ND ND
MM_0171 OD 22.87 0.7 Yes 3 47.18 25,566 12.18 6.01 0.49
OS 22.74 0.76 Yes 3 ND ND ND ND ND
MM_0239 OD 23.33 0.72 Yes 4 66.84 16,070 18.00 6.56 0.36
OS 23.23 0.9 Yes 4 58.40 13,148 17.09 6.44 0.38
MM_0251 OD 29.61 0.72 Yes 3 72.73 ND ND ND ND
OS 29.51 0.66 Yes 3 ND ND ND ND ND
MM_0358 OD 23.62 0.82 No 2 94.36 ND ND ND ND
OS 23.52 0.88 No 2 ND ND ND ND ND
MM_0385 OD 24.41 0.8 No 4 ND ND ND ND ND
OS 24.35 0.8 No 4 39.32 2,191 27.86 13.81 0.50
MM_0386 OD 24.1 0.98 Yes 2 94.36 13,148 12.93 3.85 0.30
OS 23.38 LP Yes 2 ND ND ND ND ND
MM_0387 OD 22.89 0.84 Yes 4 74.7 ND ND ND ND
OS 22.88 0.88 Yes 4 ND ND ND ND ND
MM_0396 OD 23.63 1 Yes 2 ND ND ND ND ND
OS 23.6 1.02 Yes 2 90.12 ND ND ND ND
MM_0397 OD 22.15 0.96 No 2 96.33 ND ND ND ND
OS 21.92 0.96 No 2 ND ND ND ND ND
MM_0398 OD 23.18 1 Yes 2 53.08 20,453 8.68 1.69 0.20
OS 23.49 1.12 Yes 2 49.15 19,722 8.44 1.42 0.17
MM_0412 OD 23.36 1 Yes 2 57.01 ND ND ND ND
OS 23.37 1.02 Yes 2 ND ND ND ND ND
MM_0418 OD 24.2 0.9 No 2 64.04 ND ND ND ND
OS 24.36 0.8 No 2 ND ND ND ND ND
MM_0445 OD 22.72 1 Yes 2 62.91 ND ND ND ND
OS 22.87 1 Yes 2 ND ND ND ND ND
MM_0446 OD 24.81 0.76 Yes 4 70.76 6,574 18.90 6.45 0.34
OS 24.91 0.7 Yes 4 73.32 5,844 20.69 7.18 0.35
JC_0578 OD 27.21 ND Yes 2 79.87 ND ND ND ND
OS 26.47 ND Yes 2 ND ND ND ND ND
JC_0615 OD 25.63 ND No 3 ND ND ND ND ND
OS 25.65 ND No 3 74.88 ND ND ND ND
JC_0626 OD 28.85 ND Yes 2 114.82 ND ND ND ND
OS 28.35 ND Yes 2 ND ND ND ND ND
JC_0674 OD 25.02 ND Yes 4 ND ND ND ND ND
OS 24.36 ND Yes 4 64.90 ND ND ND ND
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foveal hypoplasia. The absolute difference in ONL thickness
between right and left eyes (mean 6 SD) was 4.16 6 2.31 lm.
ONL thickness did not differ significantly between eyes (P ¼
0.754, t¼ 0.329, df ¼ 6), with mean (6SD) ONL thickness, in
lm, of 59.03 (617.92) and 59.65 (618.68) for right and left
eyes, respectively.
Peak foveal cone density was also comparable bilaterally (P
¼ 0.829, t¼ 0.225, df¼ 6), with mean 6 SD of 14,400 6 7,078
cones/mm2 and 14,087 6 9,304 cones/mm2 for the right and
left eyes, respectively. The difference in peak foveal cone
density (mean 6 SD) between eyes was 2,609 6 2,380 cones/
mm2. ICDs were also similar bilaterally (P¼ 0.496, t¼ 0.725, df
¼ 6), with mean 6 SD of 15.72 6 5.25 lm and 15.09 6 6.16
lm for right and left eyes, respectively. The mean 6 SD of CV
was 0.31 6 0.07 and 0.30 6 0.09 for right and left eyes,
respectively; indicating that mosaic topography was similar
between eyes (P ¼ 0.448, t ¼ 0.812, df ¼ 6).
Intrafamilial Variability. We recruited three pairs of
siblings (Tables 1 and 2; MM_0008-MM_0009, MM_0386-
MM_0387, and MM_0396-MM_0397), four siblings
(MM_0014, MM_0015, MM_0016, and MM_0239), and a
mother with two sons (MM_0164, MM_0165, and MM_0445,
respectively) (Tables 1, 2). Two pairs of siblings (MM_0008-
MM_0009 and MM_0396-MM_0397) had the same EZ grade
and comparable ONL thickness (mean difference among
siblings of 3 lm). AOSLO data were analyzable in only one of
those four subjects. The four siblings (MM_0014, MM_0015,
MM_0016, and MM_0239) had substantial variability of their
cone mosaics even though their EZ grade was the same (grade
4). AOSLO imaging was available for all four siblings (three
bilaterally) (Fig. 5A). The cone mosaic was variably disrupted,
without any specific pattern among these subjects. Despite the
differences in remnant cone structure, the subject with the
lowest peak foveal cone density (right/left eye, 6,574 and
7,305 cones/mm2, respectively) had the best BCVA among his
siblings. For the last pair of siblings and the family with the
three affected members, only one cone mosaic per family
could be analyzed and no conclusion about the intrafamilial
variability of their mosaics could be drawn. However, in both
families there was a notable difference in the disruption of the
photoreceptor mosaic on OCT; the two siblings MM_0386 and
MM_0387 had grade 2 and 4 EZs, respectively, and from the
other pedigree, two subjects had grade 2 and one grade 4 EZs
(Fig. 5B). BCVA was comparable among these subjects (Table
2).
DISCUSSION
The foveal cone mosaic in CNGA3-ACHM was irregular,
variably disrupted, and showed significantly lower peak foveal
cone density than unaffected individuals. A striking structural
feature that was clear in our cohort was the irregular size and
shape of the remnant inner segments (Figs. 2, 4, 5).
Irregularities in shape and size have been described in the
limited number of histology reports in patients with
ACHM.50–52 In all three reports, the patients were well
phenotyped but not genotyped, because it was before the
discovery of the ACHM genes. The unusual shape of the inner
segments was attributed to the presence of ectopic nuclei.50–52
Using OCT imaging, Genead et al.29 previously reported a
substantial variation in phenotype even in subjects with the
same genotype. Our subjects with CNGA3-ACHM had a
significantly thinner ONL than unaffected individuals, although
there was significant variability between subjects. No correla-
tion was found between peak foveal cone density and ONL
thickness. Our findings are in keeping with previous reports
for CNGB3-ACHM.36 There was a broad range of cone densities
within each EZ grade. This dissociation between OCT and peak
foveal cone density highlights the value of AOSLO for patient
stratification and evaluation of retinal potential for therapy
trials. Notable examples are subjects MM_0015 (Fig. 5) and
MM_0171 (Fig. 2), who despite being graded as 4 and 3,
respectively, have a peak foveal cone density higher than the
average for the cohort and may thus be good candidates for an
intervention. However, it is still unclear what should be
considered as a threshold and which metric will best correlate
with outcome. We will certainly be in a better position to
address these questions when the results of the current gene
therapy trials using AOSLO are released.
Despite the vast variability among subjects, interocular
symmetry was observed in all aspects examined, including
axial length, BCVA, EZ grade, presence of foveal hypoplasia,
ONL thickness, peak foveal cone density, and mosaic geometry
(ICD and CV). This information is of high value both for eye
selection for an intervention, as well as for longitudinal
evaluation of the outcome of ongoing and upcoming trials, in
which the nontreated eye can serve as a control. Overall,
TABLE 2. Continued
Subject Eye
Axial
Length,
mm
BCVA,
LogMAR
Foveal
Hypoplasia
EZ
Grade
ONL
Thickness,
lm
PFD,
Cones/mm2
ICD
Mean,
lm
ICD
SD (r)
ICD
CV
JC_0698 OD 24.27 0.9 Yes 4 ND ND ND ND ND
OS 23.79 0.9 Yes 4 73.63 ND ND ND ND
JC_1240 OD 21.62 0.4 No 4 64.90 ND ND ND ND
OS 21.72 0.54 No 4 ND ND ND ND ND
JC_10008 OD 22.62 ND Yes 4 71.14 ND ND ND ND
OS 22.76 ND Yes 4 ND ND ND ND ND
JC_10069 OD 23.13 0.8 Yes 2 67.39 40,906 7.10 1.29 0.18
OS 23.59 0.8 Yes 2 ND ND ND ND ND
KS_10088 OD 25.19 ND Yes 2 123.55 21,183 11.56 3.80 0.33
OS 25.34 ND Yes 2 ND ND ND ND ND
KS_10337 OD 23.29 1.0 No 1 71.14 54,785 6.07 1.28 0.21
OS 23.78 0.88 No 1 ND ND ND ND ND
JC_10551 OD 22.46 0.9 Yes 1 ND ND ND ND ND
OS 22.39 0.9 Yes 1 97.34 ND ND ND ND
ND, no data; BCVA, best corrected visual acuity; EZ, ellipsoid zone; PFD, peak foveal cone density; ICD, intercell distance; SD, standard deviation;
CV, coefficient of variation; ONL, outer nuclear layer; LP, light perception.
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FIGURE 3. Results summary and graphical representation. (A) Distribution of our cohort according to OCT grading, with the vast majority having
either grade 2 or 4. (B) Scatter plot of ONL thickness and age. No correlation was found. (C) Stacked scatterplot of ONL thickness and OCT EZ
grade, showing the vast variability within and between grades, as well as a trend of decreasing ONL thickness with increasing grade. (D) Stacked
scatterplot of peak cone density and OCT EZ showing the overlap between grades. In (C) and (D), individual data points within each EZ grade are
displaced horizontally for better visibility. (E) Peak cone densities of all subjects with CNGA3-ACHM included in this study plotted against age. (F)
Peak cone densities of all subjects with CNGB3-ACHM previously reported by Langlo et al.36 plotted against age on the same scale as (E). The
CNGA3 cohort plotted on (E) shows a weak negative correlation between peak cone density and age (Pearson r ¼0.397, P ¼ 0.102).
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CNGA3-ACHM appears to be a structurally symmetric disease
in keeping with previous literature that did not use AOSLO.19
Many subjects had a variable degree of foveal hypoplasia,
which is consistent with previous studies both for CNGA3 and
CNGB3.19,29,36 No difference in BCVA was noted between eyes
with and without foveal hypoplasia, in contrast to previous
studies that suggested better19 or worse40 BCVA in the
presence of foveal hypoplasia. As previously suggested by
Thomas et al.,53 incomplete centrifugal displacement of the
inner retinal layers is a common finding. No current literature
has investigated the mechanism/molecular basis of foveal
hypoplasia in ACHM.
The majority of subjects had missense sequence variants,
suggesting little tolerance for substitutions, in agreement with
the high degree of evolutionary conservation of the CNGA3
gene.17 There was marked genetic variability, although no
genotype-phenotype correlation could be observed. There is a
notable intrafamilial variability of the cone mosaic topography
and of the peak foveal cone density (Fig. 5). EZ grade and ONL
thickness were far less sensitive in detecting structural
differences, which again illustrates a disconnect between
OCT and AOSLO. In other cases, intrafamilial variability was
also clear on OCT. The observed marked intrafamilial variability
in CNGA3-ACHM shows a lack of genotype-phenotype
correlation in ACHM caused by CNGA3 variants, with specific
genetic variants not being predictive of remnant cone
structure.
Thiadens et al.54 and Thomas et al.40 suggested an age-
dependent ONL thinning.54 In contrast, Sundaram et al.19 and
Aboshiha et al.20 did not identify such a relationship. Langlo et
al.35 in a longitudinal CNGB3 assessment reported increasing
ONL thickness over time (6–26 months). In our cohort, no
FIGURE 4. Disease symmetry in CNGA3-associated ACHM. Left and right column: split-detection AOSLO images of the right and left eye respectively
of three subjects with CNGA3-ACHM. Middle column: horizontal transfoveal OCT scans of the same subjects. White arrowheads point to the
respective AOSLO image. The red horizontal bars mark the 300-lm area represented in the AOSLO images. There is substantial variability in foveal
photoreceptor mosaic between the three subjects. There are structural similarities in the mosaic pattern of the right and left eyes of each subject;
MM_0002 and MM_0064 have noncontiguous sparse foveal mosaics and MM_0398 has a relatively contiguous mosaic. MM_0002 has OCT grade 4
bilaterally with foveal hypoplasia. MM_0064 and MM_0398 have EZ grade 2 bilaterally.
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correlation between ONL thickness and age was found.
Previously Sundaram et al.19 suggested a wider window of
opportunity for intervention in ACHM and no age-dependent
association in retinal structure disruption, identifying the need
for the specific measurement of remnant photoreceptor
structure, with SD-OCT and AOSLO imaging for stratification
of patients and evaluating intervention efficacy.
While there was no association between age and ONL
thickness, we observed a weak negative association between
age and peak foveal cone density (Fig. 3E) as well as age and EZ
grade. While a similar cross-sectional study of CNGB3-ACHM
showed an association between age and EZ grade,36 that study
reported no relationship between age and peak foveal cone
density (Fig. 3F). In the aforementioned CNGB3 study, the
subcohort imaged successfully with AOSLO had a mean age
(6SD), in years, of 23.4 (610.3) and our cohort had a mean age
(6SD) of 28.3 (613.8), with the age distribution not differing
significantly among the two studies (P ¼ 0.186, t ¼ 1.35, df ¼
42). The mean peak foveal cone density is also similar between
the two studies (P¼ 0.71, Mann-Whitney test). No distinguish-
ing phenotypic characteristics could be identified for our
CNGA3 genotype compared to the current literature for
CNGB3. Similarity in CNGA3- and CNGB3-associated ACHM
was also observed in the data from microperimetry, fundus
autofluorescence, and OCT by Aboshiha et al.20 and Sundaram
et al.19
The proteins encoded by CNGA3 and CNGB3 have been
well characterized, and differences in their function may relate
to the age-dependent decline that we observed in our CNGA3
cohort, in contrast to the previously well characterized CNGB3
cohort using the same methodology.36 It has been shown than
the a subunits expressed by CNGA3 are responsible for the ion-
FIGURE 5. Intrafamilial variability in CNGA3-associated ACHM. (A) Split-detection AOSLO images of four siblings with CNGA3-ACHM. MM_0016
(VA, 0.86 LogMAR) and MM_0239 (VA, 0.90 LogMAR) are males, 30 and 37 years old, respectively. MM_0015 (VA, 0.84 LogMAR) and MM_0014 (VA,
0.74 LogMAR) are females, 28 and 35 years old, respectively. There is substantial variability in foveal photoreceptor mosaic across the four subjects,
which is independent of sex or age. All four siblings have EZ grade 4 bilaterally with foveal hypoplasia. The identification of 40 cones within the 553
55-lm sampling window resulted in a density of 13,148 cones/mm2 for both siblings, MM_0016 and MM_0239. However, other parameters such as
the ICD were different, reflecting the geometry of cones over the foveal center; MM_0239 had greater mean ICD due to a sparser mosaic in the
inferior fovea. The red cross marks the location of peak foveal cone density. (B) Transfoveal OCT scans of subjects MM_0164, MM_0165, and
MM_0445, from a single family. Female subject MM_0164 (VA, 0.92 LogMAR, mother of the male siblings MM_0165 and MM_0445) has a better
preserved EZ than the 25 year younger subject MM_0165 (VA, 0.84 LogMAR); and subject MM_0445 (VA, 1.0 LogMAR) has a nearly continuous EZ.
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conducting activity of the cation channel and the b subunits
modulate the activity.55,56 It has also been shown in CNGA3/
mice that the loss of CNGA3 expression impairs the correct
localization of cone opsins as well as the expression of other
proteins of the visual cycle, with this inducing apoptotic cell
death in cones.57 In the CNGB3/ mice, a downregulation of
CNGA3 gene expression of ~90% has been observed.58 The
residual CNGA3 expression may account for the preservation
of remnant cones in CNGB3-ACHM. By extension, the
complete absence/greater reduction of CNGA3 expression
may lead to an age-dependent decline of remnant cones in
CNGA3-ACHM (as we observe), also bearing in mind that a
subunits in vitro can form channels in the absence of b
subunits, a property not shared by b subunits.59
However, given the limitations of the cross-sectional nature
of this study, a longitudinal assessment and further evaluation
of the progressive or stationary nature of CNGA3-ACHM would
be invaluable. Longitudinal studies are necessary to properly
address the question of cone loss over time. The lack of studies
using AOSLO in age-matched subjects in order to investigate
possible age-related decline in healthy eyes makes it challeng-
ing to put our findings in context. The current literature in
healthy eyes is inconclusive for possible age-dependent
changes in peak foveal cone density, either using histology or
AO retinal imaging.60–63 Nevertheless, in agreement with
previous reports,29,36,59 all of the subjects in the present study
had remnant cone structure (across the entire age range
studied). However, no functional assessment of those cones
was possible, which will be interesting both in terms of disease
natural history and for assessing the outcomes of any
intervention.64 Despite the observed decrease of peak foveal
cone density with age, there were several notable exceptions,
with high peak foveal cone density in older subjects and no
clear age cutoff identified. This shows that despite the
statistical relationship, there is still great variability in cone
populations across all ages and, thus, the need for longitudinal
studies.
Analyzable AOSLO was achieved in only 18/38 subjects and
can be attributed to nystagmus in the vast majority of subjects,
as well as to poor optical media and high myopia in some.
Nystagmus (or absence thereof) has not been correlated with
either lower or higher remnant photoreceptor structure in the
current literature. Nystagmus in ACHM has previously been
reported to improve over time,65,66 and given the stationary, or
only slowly progressive, natural history of the condition, our
reported peak foveal cone densities are likely representative of
the CNGA3 genotype. In this study, subjects with strong
nystagmus, in which AOSLO was not analyzable, had a range
of EZ grades on OCT, further supporting that nystagmus is not
representative of the structural severity of the disease or
remnant cone architecture. We anticipate that the challenge
nystagmus poses to imaging quality will be ameliorated with the
use of eye tracking in the near future.67–69 In addition to the low
successful acquisition rate, several other factors should be taken
into account when considering using AOSLO in research studies
or even clinical practice; acquisition time is considerable and
requires the participation of two investigators for our custom-
built system, with processing, montaging, and analysis being
substantial bottlenecks. Newly developed software for simplify-
ing the steps of the process are of high value for the field, such
as montaging45,70 and cone counting.71–75
In conclusion, CNGA3-ACHM retinas can be successfully
imaged with split-detection AOSLO, with most findings in
keeping with CNGB3-ACHM. To the best of our knowledge, we
report the largest CNGA3-ACHM study to include split-
detection AOSLO imaging. There is a need for prospective
longitudinal studies of large cohorts of molecularly confirmed
CNGA3 subjects to improve our understanding of the cellular
natural history.76 Given the large variability in cone mosaics,
subjects with ACHM should be assessed on an individual basis
for selection in future and ongoing clinical trials.
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